| abstract |
(57) [Summary] (Modified) [Objective] The present invention provides a compound which is an inhibitor of HMG-CoA reductase and is useful for the treatment of hypercholesterolemia, hyperlipoproteinemia and atherosclerosis. provide. [Structure] A compound represented by formula (I) or formula (II) And a method for producing the same. [In the formula, tet is 1H-tetrazol-5-yl, 1- (C 1 -C 4 alkyl) - tetrazol-5-yl, 1 -{(2-methoxy-ethoxy) methyl} -tetrazol-5-yl; R 1 , R 4 are hydrogen, halogen, C 1 -C 4 alkyl, C 1 -C 4 alkoxy, CF 3; R 2, R 3 , R 5, R 6 are hydrogen, halogen, C 1 ~ C 4 alkyl, C 1 -C 4 alkoxy; R 7 is an amino acid] |